Clinical Trial Update: Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating hydroxyurea for beta-thalassemia (Cooley's anemia) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Hemoglobinopathy

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Beta Thalassemia, Hemoglobinopathy | Phase 2 | Status: COMPLETED